Contract research firm set to double in size following GBP700k investment
Gentronix, the UK-based contract research organisation (CRO) in the field of genetic toxicology, has raised GBP700,000 in a funding round led by existing investor Mercia to support its continued growth. The latest round, which includes a number of private investors, follows Gentronix’s recent acquisition of the Big Blue® transgenic mutation
